{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T04:55:40Z","timestamp":1776056140548,"version":"3.50.1"},"reference-count":66,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T00:00:00Z","timestamp":1776038400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Esophageal cancer (EC) lacks robust biomarkers to guide prognosis and therapy. Histone chaperone\u2013related genes (HCRGs) shape chromatin states, but their roles in EC remain unclear. We integrated histone chaperone\u2013based transcriptomic stratification with two-sample Mendelian randomization (MR) to identify genes with genetic evidence consistent with EC susceptibility and clinical relevance.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>RNA-seq and clinical data from TCGA-ESCA (184 tumors with available RNA-seq data and 13 normal samples) and an external cohort (GSE53624; 119 tumors, 119 normals) were analyzed. Prognosis-associated HCRGs informed unsupervised clustering. Differentially expressed genes common to cluster and tumor-versus-normal contrasts entered a two-sample MR framework using eQTL instruments and an EC GWAS (998 cases, 475,308 controls; European ancestry). Sensitivity analyses and the Steiger directionality test were then performed, followed by expression analysis to identify hub genes. We assessed survival associations, performed functional enrichment and immune deconvolution (CIBERSORT), modeled drug sensitivity (GDSC-based prediction), built a clinicogenomic nomogram, and validated expression by RT-qPCR in paired tissues.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>HCRG-based clustering separated patients with distinct overall survival. MR implicated 26 genes in EC risk; among these, ADORA2B and SAPCD2 were consistently overexpressed in tumors (external validation and RT-qPCR) yet higher tumor expression predicted longer survival. Both genes were linked to cell-cycle and spliceosome programs; ADORA2B showed additional immuno-metabolic enrichment, whereas SAPCD2 mapped to metabolic\/proteostasis pathways. High-expression groups exhibited reduced regulatory T-cell proportions and broader immune shifts. Predicted drug response suggested greater sensitivity to vinorelbine\/etoposide but reduced sensitivity to paclitaxel in ADORA2B\/SAPCD2-high tumors. A prognostic nomogram combining gene expression with stage and nodal status achieved 1\u20133-year AUCs of 0.67\u20130.75.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Integrating HCRG-guided stratification with MR nominates ADORA2B and SAPCD2 as MR-supported biomarkers that are overexpressed in EC yet mark favorable prognosis, a pattern consistent with a less immunosuppressive microenvironment and distinct chemosensitivity. These genes warrant histology-stratified validation and mechanistic studies and may aid risk stratification and therapeutic decision-making.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fonc.2026.1764927","type":"journal-article","created":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T04:37:02Z","timestamp":1776055022000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Histone chaperone-based stratification combined with two-sample Mendelian randomization identifies ADORA2B and SAPCD2 as prognostic biomarkers in esophageal cancer"],"prefix":"10.3389","volume":"16","author":[{"given":"Bihan","family":"Xia","sequence":"first","affiliation":[{"name":"Department of Gastroenterology and Hepatology, West China Hospital, Sichuan University","place":["Chengdu, Sichuan, China"]},{"name":"Sichuan University-University of Oxford Huaxi Joint Centre for Gastrointestinal Cancer, Frontiers Science Center for Disease-Related Molecular Network, West China Hospital, Sichuan University","place":["Chengdu, Sichuan, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuzhi","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, West China Hospital, Sichuan University","place":["Chengdu, Sichuan, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rui","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Endoscopy, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, Affiliated Cancer Hospital of University of Electronic Science and Technology of China","place":["Chengdu, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kai","family":"Deng","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, West China Hospital, Sichuan University","place":["Chengdu, Sichuan, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,4,13]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"B2","doi-asserted-by":"publisher","first-page":"17048","DOI":"10.1038\/nrdp.2017.48","article-title":"Oesophageal cancer","volume":"3","author":"Smyth","year":"2017","journal-title":"Nat Rev Dis Primers."},{"key":"B3","doi-asserted-by":"publisher","first-page":"e074962","DOI":"10.1136\/bmj-2023-074962","article-title":"Advances in diagnosis and management of cancer of the esophagus","volume":"385","author":"Deboever","year":"2024","journal-title":"BMJ."},{"key":"B4","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1038\/s41571-023-00757-y","article-title":"Improving outcomes in patients with oesophageal cancer","volume":"20","author":"Shah","year":"2023","journal-title":"Nat Rev Clin Oncol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)33326-3","article-title":"Global surveillance of trends in cancer survival 2000-14 (CONCORD-3): analysis of individual records for 37\u2008513\u2008025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries","volume":"391","author":"Allemani","year":"2018","journal-title":"Lancet."},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2010.01.004","article-title":"Chaperoning histones during DNA replication and repair","volume":"140","author":"Ransom","year":"2010","journal-title":"Cell."},{"key":"B7","doi-asserted-by":"publisher","first-page":"5010","DOI":"10.1016\/j.cell.2024.07.006","article-title":"A replisome-associated histone H3-H4 chaperone required for epigenetic inheritance","volume":"187","author":"Yu","year":"2024","journal-title":"Cell."},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1038\/s41568-020-00330-0","article-title":"Solid tumours hijack the histone variant network","volume":"21","author":"Ghiraldini","year":"2021","journal-title":"Nat Rev Cancer."},{"key":"B9","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/s12943-018-0826-9","article-title":"Enhanced expression of histone chaperone APLF associate with breast cancer","volume":"17","author":"Majumder","year":"2018","journal-title":"Mol Cancer."},{"key":"B10","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1016\/j.ccell.2019.08.006","article-title":"Dynamic incorporation of histone H3 variants into chromatin is essential for acquisition of aggressive traits and metastatic colonization","volume":"36","author":"Gomes","year":"2019","journal-title":"Cancer Cell"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2019-318668","article-title":"Histone chaperone FACT complex mediates oxidative stress response to promote liver cancer progression","volume":"69","author":"Shen","year":"2020","journal-title":"Gut."},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-19-0780","article-title":"In vivo epigenetic CRISPR screen identifies asf1a as an immunotherapeutic target in kras-mutant lung adenocarcinoma","volume":"10","author":"Li","year":"2020","journal-title":"Cancer Discov"},{"key":"B13","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1038\/s43018-021-00316-3","article-title":"SETD2 loss perturbs the kidney cancer epigenetic landscape to promote metastasis and engenders actionable dependencies on histone chaperone complexes","volume":"3","author":"Xie","year":"2022","journal-title":"Nat Cancer."},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.k601","article-title":"Reading Mendelian randomisation studies: a guide, glossary, and checklist for clinicians","volume":"362","author":"Davies","year":"2018","journal-title":"BMJ"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkw1133","article-title":"The new NHGRI-EBI Catalog of published genome-wide association studies (GWAS Catalog)","volume":"45","author":"MacArthur","year":"2017","journal-title":"Nucleic Acids Res"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1007\/s10654-015-0011-z","article-title":"Using published data in Mendelian randomization: a blueprint for efficient identification of causal risk factors","volume":"30","author":"Burgess","year":"2015","journal-title":"Eur J Epidemiol."},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/dyy262","article-title":"An examination of multivariable Mendelian randomization in the single-sample and two-sample summary data settings","volume":"48","author":"Sanderson","year":"2019","journal-title":"Int J Epidemiol."},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14225584","article-title":"Histone chaperones and digestive cancer: A review of the literature","volume":"14","author":"Zhao","year":"2022","journal-title":"Cancers (Basel)."},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.682002","article-title":"Identification of CDK2-related immune forecast model and ceRNA in lung adenocarcinoma, a pan-cancer analysis","volume":"9","author":"Liu","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1089\/omi.2009.0083","article-title":"ConsensusCluster: a software tool for unsupervised cluster discovery in numerical data","volume":"14","author":"Seiler","year":"2010","journal-title":"OMICS."},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btw313","article-title":"Complex heatmaps reveal patterns and correlations in multidimensional genomic data","volume":"32","author":"Gu","year":"2016","journal-title":"Bioinformatics."},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1576","DOI":"10.12688\/f1000research.16409.2","article-title":"gganatogram: An R package for modular visualisation of anatograms and tissues based on ggplot2","volume":"7","author":"Maag","year":"2018","journal-title":"F1000Res."},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1089\/omi.2011.0118","article-title":"clusterProfiler: an R package for comparing biological themes among gene clusters","volume":"16","author":"Yu","year":"2012","journal-title":"OMICS."},{"key":"B25","doi-asserted-by":"publisher","first-page":"e34408","DOI":"10.7554\/eLife.34408","article-title":"The MR-Base platform supports systematic causal inference across the human phenome","volume":"7","author":"Hemani","year":"2018","journal-title":"Elife."},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btw373","article-title":"PhenoScanner: a database of human genotype-phenotype associations","volume":"32","author":"Staley","year":"2016","journal-title":"Bioinformatics."},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/dyv080","article-title":"Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression","volume":"44","author":"Bowden","year":"2015","journal-title":"Int J Epidemiol."},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1002\/gepi.21965","article-title":"Consistent estimation in mendelian randomization with some invalid instruments using a weighted median estimator","volume":"40","author":"Bowden","year":"2016","journal-title":"Genet Epidemiol."},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/dyx102","article-title":"Robust inference in summary data Mendelian randomization via the zero modal pleiotropy assumption","volume":"46","author":"Hartwig","year":"2017","journal-title":"Int J Epidemiol."},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1038\/s41588-018-0099-7","article-title":"Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases","volume":"50","author":"Verbanck","year":"2018","journal-title":"Nat Genet"},{"key":"B31","doi-asserted-by":"publisher","first-page":"e107468","DOI":"10.1371\/journal.pone.0107468","article-title":"pRRophetic: an R package for prediction of clinical chemotherapeutic response from tumor gene expression levels","volume":"9","author":"Geeleher","year":"2014","journal-title":"PloS One"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2011.09.029","article-title":"Coding-independent regulation of the tumor suppressor PTEN by competing endogenous mRNAs","volume":"147","author":"Tay","year":"2011","journal-title":"Cell."},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2017.03.103","article-title":"Long non-coding RNA HOTAIR functions as miRNA sponge to promote the epithelial to mesenchymal transition in esophageal cancer","volume":"90","author":"Xu","year":"2017","journal-title":"BioMed Pharmacother."},{"key":"B34","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1186\/s12943-021-01455-y","article-title":"Long non-coding RNA NORAD\/miR-224-3p\/MTDH axis contributes to CDDP resistance of esophageal squamous cell carcinoma by promoting nuclear accumulation of \u03b2-catenin","volume":"20","author":"Jia","year":"2021","journal-title":"Mol Cancer."},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.00049.2017","article-title":"Pharmacology of adenosine receptors: the state of the art","volume":"98","author":"Borea","year":"2018","journal-title":"Physiol Rev"},{"key":"B36","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.pharmthera.2019.01.003","article-title":"The adenosine A2B G protein-coupled receptor: Recent advances and therapeutic implications","volume":"198","author":"Vecchio","year":"2019","journal-title":"Pharmacol Ther"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.CIR-19-0833","article-title":"The expression of adenosine A2B receptor on antigen-presenting cells suppresses CD8+ T-cell responses and promotes tumor growth","volume":"8","author":"Chen","year":"2020","journal-title":"Cancer Immunol Res"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1039\/d5ra02235e","article-title":"Therapeutic potential of adenosine receptor modulators in cancer treatment","volume":"15","author":"Maity","year":"2025","journal-title":"RSC Adv"},{"key":"B39","doi-asserted-by":"publisher","first-page":"995","DOI":"10.20892\/j.issn.2095-3941.2024.0228","article-title":"Adenosine signaling in tumor-associated macrophages and targeting adenosine signaling for cancer therapy","volume":"21","author":"Yang","year":"2024","journal-title":"Cancer Biol Med"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1038\/nrd2638","article-title":"Adenosine receptors: therapeutic aspects for inflammatory and immune diseases","volume":"7","author":"Hask\u00f3","year":"2008","journal-title":"Nat Rev Drug Discov"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1593\/neo.09768","article-title":"A(2B) and A<(>3<)> adenosine receptors modulate vascular endothelial growth factor and interleukin-8 expression in human melanoma cells treated with etoposide and doxorubicin","volume":"11","author":"Merighi","year":"2009","journal-title":"Neoplasia."},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1027838","article-title":"Adenosine signaling: Optimal target for gastric cancer immunotherapy","volume":"13","author":"Wang","year":"2022","journal-title":"Front Immunol"},{"key":"B43","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1007\/s12072-019-10003-2","article-title":"Targeting adenosinergic pathway enhances the anti-tumor efficacy of sorafenib in hepatocellular carcinoma","volume":"14","author":"Liao","year":"2020","journal-title":"Hepatol Int"},{"key":"B44","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1186\/s12876-025-03768-4","article-title":"To verify the biological characteristics of disulfidptosis associated gene ADORA2B in esophageal cancer","volume":"25","author":"Cui","year":"2025","journal-title":"BMC Gastroenterology."},{"key":"B45","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1186\/s12885-025-14102-2","article-title":"ADORA2B promotes proliferation and migration in head and neck squamous cell carcinoma and is associated with immune infiltration","volume":"25","author":"Li","year":"2025","journal-title":"BMC Cancer."},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.2147\/JIR.S501850","article-title":"Comprehensive bioinformatics analyses and experimental validation of the cell cycle related protein SAPCD2 as a new biomarker and potential therapeutic target in pancreatic cancer","volume":"18","author":"Liu","year":"2025","journal-title":"J Inflammation Res"},{"key":"B47","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s12935-020-1121-6","article-title":"Overexpression of SAPCD2 correlates with proliferation and invasion of colorectal carcinoma cells","volume":"20","author":"Luo","year":"2020","journal-title":"Cancer Cell Int"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.574383","article-title":"Silencing SAPCD2 represses proliferation and lung metastasis of fibrosarcoma by activating hippo signaling pathway","volume":"10","author":"Zhu","year":"2020","journal-title":"Front Oncol"},{"key":"B49","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1038\/s41419-022-04624-z","article-title":"SAPCD2 promotes neuroblastoma progression by altering the subcellular distribution of E2F7","volume":"13","author":"Zhang","year":"2022","journal-title":"Cell Death Dis"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1007\/s00432-016-2328-8","article-title":"Depletion of p42.3 gene inhibits proliferation and invasion in melanoma cells","volume":"143","author":"Liu","year":"2017","journal-title":". J Cancer Res Clin Oncol"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20205139","article-title":"A2B adenosine receptor and cancer","volume":"20","author":"Gao","year":"2019","journal-title":"Int J Mol Sci"},{"key":"B52","doi-asserted-by":"publisher","first-page":"6268","DOI":"10.1038\/s41467-020-20019-0","article-title":"Immune suppressive landscape in the human esophageal squamous cell carcinoma microenvironment","volume":"11","author":"Zheng","year":"2020","journal-title":"Nat Commun"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.115142","article-title":"Why Treg should be the focus of cancer immunotherapy: The latest thought","volume":"168","author":"Liu","year":"2023","journal-title":"BioMed Pharmacother."},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23094585","article-title":"Adenosine receptor A2B negatively regulates cell migration in ovarian carcinoma cells","volume":"23","author":"Campos-Contreras","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1016\/S0305-7372(96)90032-8","article-title":"Vinorelbine: an overview","volume":"22","author":"Johnson","year":"1996","journal-title":"Cancer Treat Rev"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1001\/jamasurg.2021.2373","article-title":"Long-term efficacy of neoadjuvant chemoradiotherapy plus surgery for the treatment of locally advanced esophageal squamous cell carcinoma: the NEOCRTEC5010 randomized clinical trial","volume":"156","author":"Yang","year":"2021","journal-title":"JAMA Surg"},{"key":"B57","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.canlet.2006.11.005","article-title":"Cellular response to etoposide treatment","volume":"252","author":"Montecucco","year":"2007","journal-title":"Cancer Lett"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1007\/s10388-019-00686-9","article-title":"A retrospective study of definitive chemoradiotherapy in patients with resectab le small cell neuroendocrine carcinoma of the esophagus","volume":"17","author":"Katada","year":"2020","journal-title":"Esophagus."},{"key":"B59","doi-asserted-by":"publisher","first-page":"393","DOI":"10.6004\/jnccn.2023.0019","article-title":"Esophageal and esophagogastric junction cancers, version 2","volume":"21","author":"Ajani","year":"2023","journal-title":"2023 NCCN Clin Pract Guidelines Oncol J Natl Compr Canc Netw"},{"key":"B60","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1016\/j.annonc.2022.07.003","article-title":"Oesophageal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up","volume":"33","author":"Obermannov\u00e1","year":"2022","journal-title":"Ann Oncol"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-23-0843","article-title":"Dual A2A\/A2B adenosine receptor antagonist M1069 counteracts immunosuppressive mechanisms of adenosine and reduces tumor growth in vivo","volume":"23","author":"Schiemann","year":"2024","journal-title":"Mol Cancer Ther"},{"key":"B62","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s40364-025-00784-0","article-title":"The progress and prospects of targeting the adenosine pathway in cancer immunotherapy","volume":"13","author":"Yang","year":"2025","journal-title":"biomark Res"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2012.20","article-title":"Association between BRCA1 and BRCA2 mutations and survival in women with invasive epithelial ovarian cancer","volume":"307","author":"Bolton","year":"2012","journal-title":"JAMA."},{"key":"B64","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1038\/s41416-021-01364-3","article-title":"Schlafen 11 predicts response to platinum-based chemotherapy in gastric cancers","volume":"125","author":"Takashima","year":"2021","journal-title":"Br J Cancer."},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2008.09.067","article-title":"Human equilibrative nucleoside transporter 1 levels predict response to gemcitabine in patients with pancreatic cancer","volume":"136","author":"Farrell","year":"2009","journal-title":"Gastroenterology."},{"key":"B66","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1038\/s41467-019-09381-w","article-title":"Adjustment for index event bias in genome-wide association studies of subsequent events","volume":"10","author":"Dudbridge","year":"2019","journal-title":"Nat Commun"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1764927\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T04:37:10Z","timestamp":1776055030000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1764927\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,13]]},"references-count":66,"alternative-id":["10.3389\/fonc.2026.1764927"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2026.1764927","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,13]]},"article-number":"1764927"}}